title: Effects of ghrelin on the insulin and glycemic responses to glucose, arginine, or free fatty acids load in humans.
abstract: Ghrelin possesses central and peripheral endocrine actions including influence on the endocrine pancreatic function. To clarify this latter ghrelin action, in seven normal young subjects [age (mean +/- SEM), 28.3 +/- 3.1 yr; body mass index, 21.9 +/- 0.9 kg/m(2)), we studied insulin and glucose levels after acute ghrelin administration (1.0 microg/kg i.v.) alone or combined with glucose [oral glucose tolerance test (OGTT), 100 g orally], arginine (ARG, 0.5 g/kg i.v.) or free fatty acid (FFA, Intralipid 10%, 250 ml). Ghrelin inhibited (P < 0.05) insulin and increased (P < 0.05) glucose levels. OGTT increased (P < 0.01) glucose and insulin levels. FFA increased (P < 0.05) glucose but did not modify insulin levels. ARG increased (P < 0.05) both insulin and glucose levels. Ghrelin did not modify both glucose and insulin responses to OGTT as well as the FFA-induced increase in glucose levels; however, ghrelin administration was followed by transient insulin decrease also during FFA. Ghrelin blunted (P < 0.05) the insulin response to ARG and enhanced (P < 0.05) the ARG-induced increase in glucose levels. In all, ghrelin induces transient decrease of spontaneous insulin secretion and selectively blunts the insulin response to ARG but not to oral glucose load. On the other hand, ghrelin raises basal glucose levels and enhances the hyperglycemic effect of ARG but not that of OGTT. These findings support the hypothesis that ghrelin exerts modulatory action of insulin secretion and glucose metabolism in humans.
authors.affiliation: Division of Endocrinology and Metabolism, Department of Internal Medicine, University of Turin, 10126 Torino, Italy.
authors.forename: F
authors.initials: F
authors.lastname: Broglio
authors.forename: C
authors.initials: C
authors.lastname: Gottero
authors.forename: A
authors.initials: A
authors.lastname: Benso
authors.forename: F
authors.initials: F
authors.lastname: Prodam
authors.forename: S
authors.initials: S
authors.lastname: Destefanis
authors.forename: C
authors.initials: C
authors.lastname: Gauna
authors.forename: M
authors.initials: M
authors.lastname: Maccario
authors.forename: R
authors.initials: R
authors.lastname: Deghenghi
authors.forename: A J
authors.initials: AJ
authors.lastname: van der Lely
authors.forename: E
authors.initials: E
authors.lastname: Ghigo
mesh_terms: D000328:Adult; D019540:Area Under Curve; D001120:Arginine / Q000494:pharmacology*; D001786:Blood Glucose / Q000378:metabolism*; D005230:Fatty Acids, Nonesterified / Q000494:pharmacology*; D054439:Ghrelin; D005947:Glucose / Q000494:pharmacology*; D005951:Glucose Tolerance Test; D019382:Human Growth Hormone / Q000097:blood; D006801:Humans; D006854:Hydrocortisone / Q000097:blood; D007275:Injections, Intravenous; D007328:Insulin / Q000097:blood*; D008297:Male; D010179:Pancreas / Q000187:drug effects; D036361:Peptide Hormones / Q000009:adverse effects / Q000493:pharmacokinetics / Q000494:pharmacology*
chemical_list: D001786:Blood Glucose; D005230:Fatty Acids, Nonesterified; D054439:Ghrelin; D007328:Insulin; D036361:Peptide Hormones; D019382:Human Growth Hormone; D001120:Arginine; D005947:Glucose; D006854:Hydrocortisone